<DOC>
	<DOCNO>NCT00678756</DOCNO>
	<brief_summary>Exploration antipsoriatic effect UVB-therapy +/- CYP-inhibitor Ketokonazol affect psoriatic skin</brief_summary>
	<brief_title>Investigation Antipsoriatic Effects UVB-induced Synthesis 1alpha , 25-Dihydroxyvitamin D3 ( 1alpha , 25 ( OH ) 2D3 , Calcitriol ) Keratinocytes Psoriatic Skin , Using Cytochrom-P ( CYP ) Inhibitor Ketokonazol</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dihydroxycholecalciferols</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>age : 18 80 diagnosis psoriasis vulgaris ( mild middle ) current antipsoriatic therapy ( systemic/topical ) least 5 psoriatic area 5x5 cm pregnancy/nursing mother woman reproductive age without adequate contraception severe acute form psoriasis vulgaris patient receive systemic topical antipsoroatic treatment past 3 month UVtherapy past 3 month patient positive anamnesis squamous cell carcinoma , malignant melanoma , basalioma epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Psoriasis vulgaris ,</keyword>
	<keyword>vitamin D , UVB-phototherapy , ketokonazol ,</keyword>
	<keyword>Optical Coherence Tomography ,</keyword>
	<keyword>local PASI , Nizoral</keyword>
</DOC>